Literature DB >> 7528229

CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans.

V G Prieto1, J A Reed, C R Shea.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive tumor that often recurs after simple excision, and therefore usually requires wide surgical re-excision. It is sometimes difficult to distinguish histologically between residual tumor and scar tissue formed in response to the original biopsy. In an effort to solve this diagnostic problem, we have examined CD34 immunoreactivity in 10 primary biopsies of DFSP, 12 scars, and 7 re-excisional DFSP specimens containing residual tumor adjacent to scar tissue. In all 10 primary biopsies of DFSP, the tumor cells strongly and uniformly expressed CD34. In the 12 scars, only periadnexal cells, endothelial cells, and rare, scattered dendritic cells in the dermis were immunolabeled for CD34. In the 7 re-excisions of DFSP, the foci of residual DFSP were strongly immunolabeled, while the surrounding scar tissue was not. The pattern of CD34 immunoreactivity distinguishes DFSP from scar tissue, and thereby may permit more accurate assessment of surgical margins in re-excisional specimens of DFSP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528229     DOI: 10.1111/j.1600-0560.1994.tb00707.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Congenital Dermatofibrosarcoma Protuberans: A Case Report and Literature Review.

Authors:  Hyun Ho Han; Soo Yeon Lim; Young Min Park; Jong Won Rhie
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

2.  PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.

Authors:  Khadijeh Jahanseir; Deyin Xing; Patricia T Greipp; William R Sukov; Gary L Keeney; Brooke E Howitt; J Kenneth Schoolmeester
Journal:  Int J Gynecol Pathol       Date:  2018-11       Impact factor: 2.762

3.  Clinicopathological features of dermatofibrosarcoma protuberans.

Authors:  Noppadol Larbcharoensub; Jitchai Kayankarnnavee; Suda Sanpaphant; Kidakorn Kiranantawat; Chewarat Wirojtananugoon; Vorachai Sirikulchayanonta
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

Review 4.  Dermatofibrosarcoma Protuberans in Children.

Authors:  Aseel Sleiwah; Thomas C Wright; Thomas Chapman; Adam Dangoor; Francesca Maggiani; Rachel Clancy
Journal:  Curr Treat Options Oncol       Date:  2022-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.